- 1Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway
- 2Faculty of Medicine, University of Oslo, Oslo, Norway
- 3Department of Rheumatology, Hospital for Rheumatic Diseases, Haugesund, Norway
- 4Department of Rheumatology, University of California, Los Angeles, CA, United States
- 5Department of Rheumatology, Rikshospitalet, Oslo, Norway
- 6Division of Internal Medicine, Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway
A correction on
Vascular ultrasound as a follow-up tool in patients with giant cell arteritis: a prospective observational cohort study
by Haaversen, A. C. B., Brekke, L. K., Kermani, T. A., Molberg, Ø., and Diamantopoulos, A. P. (2024). Front. Med. 11:1436707. doi: 10.3389/fmed.2024.1436707
In the published article, the Reference for ACR 1990 criteria modified by Dejaco et al. was incorrectly written as “Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. American College of Rheumatology/Vasculitis Foundation guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. (2021) 73:1349–65. doi: 10.1002/art.41774.”
It should be “Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (2017) 56:506–515. doi: 10.1093/rheumatology/kew273.”
In the published article, there was an error. There was an error in how the modified ACR 1990 criteria were named and referenced.
A correction has been made to Methods, The prospective GCA cohort, paragraph 1. This sentence previously stated:
“All the patients were classified using the ACR 1990 criteria modified by Maz et al.”
The corrected sentence appears below:
“All the patients were classified using the ACR 1990 criteria modified by Dejaco et al.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: giant cell arteritis, ultrasound, relapse, follow-up, large vessel vasculitis
Citation: Haaversen ACB, Brekke LK, Kermani TA, Molberg Ø and Diamantopoulos AP (2025) Correction: Vascular ultrasound as a follow-up tool in patients with giant cell arteritis: a prospective observational cohort study. Front. Med. 12:1635905. doi: 10.3389/fmed.2025.1635905
Received: 27 May 2025; Accepted: 29 May 2025;
Published: 12 June 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Haaversen, Brekke, Kermani, Molberg and Diamantopoulos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Anne C. B. Haaversen, QW5uZS5CdWxsLkhhYXZlcnNlbkBtaGgubm8=
†ORCID: Anne C. B. Haaversen orcid.org/0009-0000-0984-4590